|

Biomolecular Markers of Bone Metastasis

RECRUITINGN/ASponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna
Actively Recruiting
PhaseN/A
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Started2024-09-17
Est. completion2026-06-17
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06806462

Summary

The goal of this clinical trial is to characterize the biomolecular profile of bone metastases to define the predisposing profiles of bone metastasis, in patients with breast or lung or renal carcinomas or of the gastroenteric or prostate tract with bone metastasis. The main question it aims to answer is: Is it possible to predict the progression of bone metastasis by identifying biomarkers as risk factors for bone metastasis?

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age \>= 18 years
* Patients with breast or lung or renal or gastroenteric tract or prostate with bone metastases
* Patients who knowingly express willingness to participate in the study after signing the written informed consent

Exclusion Criteria:

* None

Conditions2

Bone MetastasisCancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.